Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct;61(Suppl 3):45-50.
doi: 10.20471/acc.2022.61.s3.6.

SENHANCE ROBOTIC RADICAL PROSTATECTOMY

Tomislav Kuliš  1   2 , Tvrtko Hudolin  1   2 , Luka Penezić  1 , Toni Zekulić  1 , Hrvoje Saić  1 , Tomislav Sambolić  2 , Iva Bačak Kocman  2   3 , Eleonora Goluža  2   3 , Nikola Knežević  1   2 , Željko Kaštelan  1   2
Affiliations
Review

SENHANCE ROBOTIC RADICAL PROSTATECTOMY

Tomislav Kuliš et al. Acta Clin Croat. 2022 Oct.

Abstract

Since its introduction 20 years ago, robotic radical prostatectomy has become a standard of care in the treatment of localized prostate cancer in many Centers. Until recently, they have all been performed by the only available robotic platform. Senhance is a novel robotic platform that was approved for clinical use. The term Senhance was used to systematically search PubMed and Scopus databases for relevant articles that were afterward filtered for appropriate designs and data reports. There were two reports that met all of the criteria and were included in the review. Both studies were designed as prospective case series with a total of 234 patients where the data including operative data and oncological outcomes were reported. The average operative time ranged between 180 and 195 min, with estimated blood loss between 250 and 300 mL. There was 3 Clavien - Dindo grade III, and 1 Clavien - DIndo grade IV complication reported. One of the studies compared it with laparoscopy, but no significant difference in operative time and blood loss was found. Both studies concluded that the Senhance is a feasible and safe robotic platform for radical prostatectomy.

Keywords: Robotic prostatectomy: Prostate cancer; Senhance.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of selection of articles for inclusion in the review
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sung H, Ferlay J, Siegel RL. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. 2021;71(3):209-49. - PubMed
    1. Pasticier G, Rietbergen JB, Guillonneau B, Fromont G, Menon M, Vallancien G. Robotically assisted laparoscopic radical prostatectomy: feasibility study in men. Eur Urol. 2001;40(1):70–4. 10.1159/000049751 - DOI - PubMed
    1. Gandaglia G, Montorsi F, Karakiewicz PI, Sun M. Robot-assisted radical prostatectomy in prostate cancer. Future Oncol. 2015;11(20):2767–73. 10.2217/fon.15.169 - DOI - PubMed
    1. Kulis T, Hudolin T, Penezic L. Comparison of extraperitoneal laparoscopic and extraperitoneal Senhance radical prostatectomy. 2021:e2344. - PubMed
    1. Rumolo V, Rosati A, Tropea A, Biondi A, Scambia G. Senhance robotic platform for gynecologic surgery: a review of literature. Updates Surg. 2019;71(3):419–27. 10.1007/s13304-018-00620-1 - DOI - PubMed